Tag: Pfizer

Pfizer To Acquire Medivation, Mulls Split
Stocks

Pfizer To Acquire Medivation, Mulls Split

Pfizer To Acquire Medivation, Mulls Split by PitchBook Pfizer (NYSE: PFE) has agreed to acquire Medivation (NASDAQ: MDVN), a biopharma developing commercial cancer treatments, for $81.50 a share in cash, representing a total enterprise value of $14 billion. Medivation’s primary […]